35
https://pubmed.ncbi.nlm.nih.gov/38116009
The abstract reports that targeting NAD(+) metabolism, by inhibiting its synthesis or degrading enzymes, has dual therapeutic potential in cancer treatment by limiting cancer cell proliferation and alleviating the immunosuppressive tumor microenvironment.